News / All News / Article

The Frontier of Evolution | Weiming Penguin and Tencent Successfully Hold the Chengdu Edition of the 2026 AI-Native Evolution Conference for Pharmaceutical Companies

Article images may contain Chinese text.

Approximately 2000 Chinese characters; a 6-minute read.

As the wave of digital transformation sweeps through the pharmaceutical industry, at the crossroads of “The Frontier of Evolution,” will companies actively embrace change or passively wait?


Weiming Penguin partnered with Tencent to host an AI-Native Evolution Conference in Chengdu, designed specifically for pharmaceutical companies. Industry leaders from pharmaceutical manufacturing, pharmacy chains, and digital services gathered to explore a new paradigm for pharmaceutical companies to thrive in the AI era.


 ☆ 


Welcome Address: Evolution Is the Only Answer


Teresa, Co-founder & President of Weiming Penguin, opened her welcome address with a clear message:


We stand at an unprecedented moment in history. AI is not just a tool that adds a finishing touch; it is the underlying logic redefining corporate competitiveness. Weiming Penguin and Tencent jointly initiated this conference in the hope of working with partners across the pharmaceutical industry to find our own paths of evolution.


The phrase “The Frontier of Evolution” captured the conference's central question: Amid the wave of AI, how can pharmaceutical companies make the leap from traditional operations to an intelligence-native model?


 ☆ 


Intelligent Evolution
A New Work Paradigm for Healthcare Companies Amid AI Trends


Taking a macro view of the industry, the presentation systematically reviewed the latest AI trends in healthcare:


AI is reshaping three core areas for healthcare companies:

  • Internal operations: From manual approvals to intelligent workflows, and from experience-based decisions to data-driven decisions
  • Customer service: From reactive responses to proactive outreach, with intelligent support throughout the lifecycle
  • Compliance management: AI-assisted compliance reviews to reduce the risk of human error

Adopting AI in healthcare is not simply about replacing people with AI; it is about using AI to amplify the value of human expertise.


Zhou Tiance emphasized that companies that establish a “new AI work paradigm” first will build competitive barriers that are difficult to replicate over the next 3-5 years.


 ☆ 


Intelligence Powered by StarPlex
StarPlex AI Agents Enable Growth Across Pharmaceutical Businesses


Zhao Fei, Solutions Expert at Weiming Penguin


Zhao Fei explained in detail how Weiming Penguin's flagship StarPlex AI agent platform helps pharmaceutical companies achieve growth across their businesses:

Use Case
StarPlex AI Agents
 Scientific Promotion
AI-assisted content creation and personalized outreach to HCP
Patient Education
Intelligent Q&A + Full-Lifecycle Management to Improve Adherence
Channel Management
Connect data across the business for real-time insights into channel health
Sales Enablement
Intelligent recommendations for sales messaging to improve representative visit efficiency

In the past, pharmaceutical growth depended on strength in numbers; today, it depends on an AI agent strategy.


The core logic of StarPlex is to capture a company's business experience as “agent knowledge,” enabling AI to amplify every business action.


 ☆ 


Safe Lobster Rearing: Tencent Cloud's Lobster Security Toolkit



This was the conference's most delightfully unexpected topic—using “raising lobsters” as a metaphor for building enterprise security.


The more digitally advanced the pharmaceutical industry becomes, the greater its exposure to security risks:


Water quality is the key to raising lobsters well. A solid security foundation is the key to keeping a company's digital assets operating safely.


Tencent Cloud's Lobster Security Toolkit provides pharmaceutical companies with:

  • Data security: Lifecycle protection for core business data
  • Access control: Fine-grained permissions management to prevent internal data leaks
  • Compliance audits: End-to-end traceability that meets pharmaceutical regulatory requirements
  • Threat awareness: AI-driven, real-time security situational awareness

Security is the “moat” protecting AI-native evolution.


 ☆ 


Knowledge Enablement
Weiming Penguin's Data- and AI-Driven Transformation Practices and the Lexiang Knowledge Base


Xu Dan, Solutions Expert at Weiming Penguin


Xu Dan shared Weiming Penguin's practical exploration of knowledge lifecycle management:


Beyond products and channels, pharmaceutical companies have another core asset: organizational knowledge hidden in countless documents, emails, and meeting notes.


This knowledge used to lie dormant on hard drives; now, the Lexiang Knowledge Base brings it “to life.”


The Core Value of the Lexiang Knowledge Base:

  • A unified repository for product knowledge, scientific literature, and training materials
  • AI-powered intelligent search that answers business questions in seconds
  • Faster onboarding for new employees and transfer of experienced employees' expertise
  • A closed loop of knowledge iteration: An enterprise brain that continuously evolves

 ☆ 


Shared Success Through Owned Customer Channels
A New Model for Pharmaceutical Manufacturers and Pharmacy Chains in the WeChat Ecosystem


How can pharmaceutical manufacturers and pharmacy chains move from rivalry to symbiosis in the WeChat ecosystem?


There has long been a natural tension between pharmaceutical manufacturers and retail pharmacies: manufacturers want brand exposure and control over retail outlets, while pharmacies want customer traffic and reliable margins.


Tencent Health's Digital Canal offers a new way to address this challenge:


This is not a zero-sum game, but shared success across the ecosystem. A data platform for owned customer channels on WeChat creates synergy between manufacturers' brand strength and pharmacies' service capabilities.


Core Model:

  • Manufacturers equip pharmacies with professional content, while pharmacies help manufacturers reach end users
  • Share patient data, subject to compliance requirements, so both parties can work together to enhance patient value
  • Coordinate points, memberships, and campaigns to connect the entire manufacturer–pharmacy–patient journey

 ☆ 


Roundtable Discussion: Embracing the Spirit of the “Lobster” and the “Horse”
Data- and AI-Driven Enablement × Practical AI Implementation and Joint Ecosystem Development


In the conference's grand finale, a roundtable titled “Embracing the Spirit of the ‘Lobster’ and the ‘Horse’—Data- and AI-Driven Enablement × Practical AI Implementation and Joint Ecosystem Development” brought the atmosphere to a peak.


Moderator: Liu Yinghong, Key Account Director at Weiming Penguin


Roundtable Panelists:

Panelist
Position
 Zhao Fei
Solutions Expert at Weiming Penguin
Tang Pengzhuang
Advisor to Tencent Group
Shen Yidi
Pharmaceutical Solutions Architect at Tencent Lexiang
Qin Jun
CIO, Kelun Group
Cheng Bin
Vice President, Yuheng Group

A CIO and a vice president from leading client companies joined technical experts from Tencent and Weiming Penguin for an in-depth discussion of the real challenges in implementing AI:

“The biggest pitfall in AI projects is not the technology. It is organizational change.”
“Without sound data governance, even the most powerful AI is a castle in the air.”
“Joint ecosystem development is not a slogan. It requires real financial investment and trust.”

The “lobster” symbolizes Tencent Cloud's security protection, while the “horse” represents Weiming Penguin's energy and momentum—the two working together vividly embody the spirit at the heart of this conference.


 ☆ 


We Look Forward to Seeing You at the Next Stop


Evolution has never been easy.


But as the pharmaceutical industry stands on the threshold of the AI era, companies that choose to embrace change will ultimately find their own ecological niche on this frontier of evolution.


Weiming Penguin and Tencent will continue working together to support pharmaceutical companies on their AI-native journey.


 ☆